UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes

Diabetologia, 2023-11, Vol.66 (11), p.2164-2169

2023

Volltextzugriff (PDF)

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study

BMJ open, 2021-02, Vol.11 (2), p.e045482-e045482

2021

Volltextzugriff (PDF)

Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition

Journal of the American Heart Association, 2024-06, Vol.13 (12), p.e033190

2024

Volltextzugriff (PDF)

New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4

Journal of the American College of Cardiology, 2021-03, Vol.77 (12), p.1564-1575

2021

Volltextzugriff (PDF)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?

Cardiovascular research, 2022-11, Vol.118 (14), p.2919-2931

2022

Volltextzugriff (PDF)

ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity

Journal of the American Heart Association, 2023-11, Vol.12 (21), p.e030476-e030476

2023

Volltextzugriff (PDF)

Association Between Self-Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension

Journal of the American Heart Association, 2023-11, Vol.12 (22), p.e031418

2023

Volltextzugriff (PDF)

Interleukin 6 plasma levels are associated with progression of coronary plaques

Open heart, 2024-09, Vol.11 (2), p.e002773

2024

Volltextzugriff (PDF)

Performance of an artificial intelligence-guided quantitative coronary computed tomography algorithm for predicting myocardial ischemia in real-world practice

International journal of cardiology. Heart & vasculature, 2024-08, Vol.53, p.101433, Article 101433

2024

Volltextzugriff (PDF)

New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B

Journal of the American College of Cardiology, 2021-03, Vol.77 (12), p.1564-1575

2021

Volltextzugriff (PDF)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

European heart journal, 2023-05, Vol.44 (18), p.1594-1607

2023

Volltextzugriff (PDF)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Journal of the American College of Cardiology, 2022-01, Vol.79 (3), p.223-233

2022

Volltextzugriff (PDF)

Lipoprotein(a): An underestimated inflammatory mastermind

Atherosclerosis, 2022-05, Vol.349, p.101-109

2022

Volltextzugriff (PDF)

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

European heart journal, 2020-11, Vol.41 (41), p.3998-4007

2020

Volltextzugriff (PDF)

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

European heart journal, 2022-04, Vol.43 (16), p.1569-1577

2022

Volltextzugriff (PDF)

Lp(a): a New Pathway to Target?

Current atherosclerosis reports, 2022-11, Vol.24 (11), p.831-838

2022

Volltextzugriff (PDF)

Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability

Arteriosclerosis, thrombosis, and vascular biology, 2021-06, Vol.41 (6), p.2038-2048

2021

Volltextzugriff (PDF)

Different inflammatory pathways underlying cardiovascular risk in secondary prevention

European heart journal, 2022-10, Vol.43 (38), p.3812-3812

2022

Volltextzugriff (PDF)

Considerations for routinely testing for high lipoprotein(a)

Current opinion in lipidology, 2023-08, Vol.34 (4), p.174

2023

Volltextzugriff (PDF)

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis

Heart (British Cardiac Society), 2022-01, Vol.108 (1), p.61-66

2022

Volltextzugriff (PDF)

Considerations for routinely testing for high Lp(a)

Current opinion in lipidology, 2022-06, Vol.33 (3), p.213-218

2022

Volltextzugriff (PDF)

Marked plaque regression in homozygous familial hypercholesterolemia

Atherosclerosis, 2021-06, Vol.327, p.13-17

2021

Volltextzugriff (PDF)

Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study

Atherosclerosis, 2022-01, Vol.341, p.43-49

2022

Volltextzugriff (PDF)

Response to: Correspondence on "Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis" by Pantelidis et al

Heart (British Cardiac Society), 2022-04, Vol.108 (7), p.576-577

2022

Volltextzugriff (PDF)

Finding very high lipoprotein(a): the need for routine assessment

European journal of preventive cardiology, 2022-05, Vol.29 (5), p.769-776

2022

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Cardiovascular System & Cardiology
(41)
Cardiac & Cardiovascular Systems
(36)
Humans
(33)
Female
(17)
Risk Factors
(17)
Male
(16)
Middle Aged
(15)
Aged
(14)
Peripheral Vascular Disease
(13)
Lipoprotein
(10)
Atherosclerosis
(8)
Coronary Artery Disease - Diagnostic Imaging
(8)
Coronary Angiography
(7)
Biomarkers - Blood
(6)
Computed Tomography Angiography
(6)
Prospective Studies
(6)
Heart Disease Risk Factors
(5)
Inflammation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study

Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition

New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?

ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity

Association Between Self-Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension

Interleukin 6 plasma levels are associated with progression of coronary plaques

Performance of an artificial intelligence-guided quantitative coronary computed tomography algorithm for predicting myocardial ischemia in real-world practice

New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Lipoprotein(a): An underestimated inflammatory mastermind

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

Lp(a): a New Pathway to Target?

Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability

Different inflammatory pathways underlying cardiovascular risk in secondary prevention

Considerations for routinely testing for high lipoprotein(a)

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis

Considerations for routinely testing for high Lp(a)

Marked plaque regression in homozygous familial hypercholesterolemia

Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study

Response to: Correspondence on "Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis" by Pantelidis et al

Finding very high lipoprotein(a): the need for routine assessment

Suchergebnisse filtern